Nonfatal Strongyloides Stercoralis Hyperinfection Secondary to Pemphigus Vulgaris Immunosuppressant Treatment: Case Report and Brief Literature Review

Inês Tribolet de Abreu; Pedro de Vasconcelos; Rafael Moiteiro da Cruz; Luís Soares-Almeida; Paulo Filipe

doi:10.20344/amp.22948

Nonfatal Strongyloides Stercoralis Hyperinfection Secondary to Pemphigus Vulgaris Immunosuppressant Treatment: Case Report and Brief Literature Review

Authors

Inês Tribolet de Abreu Dermatology Department. Unidade Local de Saúde Santa Maria. Lisbon. Portugal; University Clinic of Dermatology. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal. https://orcid.org/0009-0008-4497-9763
Pedro de Vasconcelos Dermatology Department. Unidade Local de Saúde Santa Maria. Lisbon. Portugal. https://orcid.org/0000-0002-7480-1228
Rafael Moiteiro da Cruz Pathology Department. Unidade Local de Saúde Santa Maria. Lisbon. Portugal; Pathology Institute. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal; Histology and Developmental Biology Institute. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal.
Luís Soares-Almeida Dermatology Department. Unidade Local de Saúde Santa Maria. Lisbon. Portugal; University Clinic of Dermatology. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal. https://orcid.org/0000-0003-4026-6105
Paulo Filipe Dermatology Department. Unidade Local de Saúde Santa Maria. Lisbon. Portugal; University Clinic of Dermatology. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal; Gulbenkian Institute for Molecular Medicine. Lisbon. Portugal. https://orcid.org/0000-0001-6917-527X

DOI:

https://doi.org/10.20344/amp.22948

Keywords:

Immunosuppressive Agents/adverse effects, Pemphigus/drug therapy, Strongyloides stercoralis, Strongyloidiasis/chemically induced, Strongyloidiasis/diagnosis, Strongyloidiasis/drug therapy, Superinfection

Abstract

N/A

Downloads

Download data is not yet available.

References

Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012;25:458-63.

Pedersen AA, Hartmeyer GN, Stensvold CR, Martin-Iguacel R. Strongyloides stercoralis hyperinfection syndrome with cerebral involvement. BMJ Case Reports. 2022;15:e24703.

Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, et al. Disseminated strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63:896-902.

Reddy IS, Swarnalata G. Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases. Indian J Dermatol Venereol Leprol. 2005;71:38-40.

Walker SL, Mann TA. Strongyloidiasis complicating immunosuppression for pemphigus vulgaris. Br J Dermatol. 2013;169:1363-4.

Downloads

Published

2025-06-02

How to Cite

Tribolet de Abreu I, de Vasconcelos P, Moiteiro da Cruz R, Soares-Almeida L, Filipe P. Nonfatal Strongyloides Stercoralis Hyperinfection Secondary to Pemphigus Vulgaris Immunosuppressant Treatment: Case Report and Brief Literature Review. Acta Med Port [Internet]. 2025 Jun. 2 [cited 2025 Dec. 5];38(6-7):431-2. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/22948

Download Citation

Issue

Vol. 38 No. 6-7 (2025): June-July

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.